ArticlePloS one2026
Investigating tryptophan metabolism in colorectal cancer using Single-cell RNA sequencing based on machine learning techniques.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColorectal cancer (CRC) is characterized by genetic variation, epigenetic alterations, microenvironmental imbalance, and metabolic reprogramming. Currently, abnormalities amino acid metabolism has been shown to play an important role in the occurrence and progression of CRC.
methodsAUCell, UCell, singscore, ssGSEA and AddModuleScore algorithms were used to determine the pattern of tryptophan metabolism in CRC at the cellular level. Differential expression and correlation analyses were performed to identify core candidate genes associated with upregulation of metabolic activity. Four machine learning algorithms--random forest, Boruta, LASSO, and gradient boosting machine-were further integrated for feature selection. Finally, to enhance robustness and reduce algorithm‑specific bias, the results of these algorithms were combined to identify the key feature genes related to tryptophan metabolism in CRC.
resultsThe findings demonstrated significant differences in tryptophan metabolic activity among different cell types in CRC, with macrophages and Paneth cells exhibiting higher activity. Among the tryptophan metabolism-related genes, CYP1A1 and aryl hydrocarbon receptor (AHR) were significantly upregulated in CRC, suggesting their involvement in regulating of immune response and inflammatory responses.
conclusionsThis study reveals, for the first time, the cellular pattern of tryptophan metabolism in CRC, with macrophages and Paneth cells playing a major role in tumor development. CYP1A1 and AHR were identified as consensus feature‑selected genes involved in tryptophan metabolism in CRC, highlighting their potential as biomarkers and therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.